Considerations on the association of atherosclerosis and rheumatoid arthritis
Keywords:
atherosclerosis, rheumatoid arthritis, association between atherosclerosis and rheumatoid arthritiseen atherosclerosis and rheumatoid arthritisAbstract
Rheumatoid arthritis and atherosclerosis are two strictly related inflammatory diseases. To show different authors' considerations on the association between atherosclerosis and rheumatoid arthritis. Rheumatoid arthritis ―related inflammation can lead to the onset of atherosclerosis in several ways. It is important to evaluate and monitor rheumatoid arthritis patients to detect the existence of existing traditional risk factors for the appearance of CVD, in order to reduce the impact on the cardiovascular system.
Downloads
References
Solomon DH., Karlson EW., Rimm EB., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-1307.
Edwards CJ., Syddall H., Goswami R., et al. Rheumatoid factor may be an Independent risk factor for ischaemic heart disease. Heart. 2007.
Meune C., Touzé E., Trinquart L., Allanore Y. “High risk of clinical cardiovascular évents in rheumatoid arthritis: lévéls of associations of myocardial infarction and stroke through a systématic review and méta-analysis,” Archives of Cardiovascular Diseases, 2010, 103(4):253-261.
Mirjafari H., Al-Husain A., Bruce I. N., “Cardiovascular risk factors in inflammatory arthritis,” Current Opinion in Lipidology, 2011, 22(4):296-301.
Roman MJ., Naqvi TZ., Gardin JM., et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr2006;19:943-954.
Chambless LE., Heiss G., Folsom AR., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494.
Kallbérg H., Ding B., Padyukov L. ét al., “Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks aíter various exposures to cigaréttésmoké,” Annals ofthe Rheumatic Diseases, 2011; 70(3):508-511.
Pemberton P. W., Ahmad Y., Bodill H. ét al., “Biomarkers of oxidant stress, insulin sensitivity and éndothélial activation in rheumatoid arthritis: a cross-sectional study of their associ- ation with accelerated atherosclerosis,” BMC Research Notes, 2009, 2(83).
Goodson N. J., Symmons D. P., Scott D. G., Bunn D., Lunt M, Silman A. J., “Basélinélévéls of C-reactive protein and prediction of déath from cardiovascular disease in patients with inflammatory polyarthritis: a tén-year followup study of a primary care-based inception cohort,” Arthritis and Rheumatism. 2005, 52(8):2293-2299.
Ku I. A., Imboden J. B., Hsué P. Y., Ganz P., “Rheuma- toid arthritis—a modél of systémic inflammation driving athérosclérosis,” Circulation Journal. 2009,73(6):977¬985.
Tanimoto N., Kumon Y., Suéhiro T. ét al., “Serum paraoxonasé activity décreases in rheumatoid arthritis,” Life Sciences. 2003, 72(25):2877-2885.
Marder W., Khalatbari S., Myles J. D. et al., “Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis,” Annals oftheRheumaticDiseases. 2011, 70(9):1550-1555,
Yiu K. H., Wang S., Mok M. Y. et al., “Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification,” Journal of Rheumatology. 2010, 37(3):529-535.
Ahmed H. M. M. S., Youssef M., Mosaad Y. M., “Anti- bodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis,” Clinical Rheumatology. 2010, 29(11):1237-1243.
Pansuria M., Xi H., Li L., Yang X. F., Wang H., “Insulin resistance, metabolic stress, and atherosclerosis,” Frontiers in Bioscience. 2012, 4:916-931.
Bresalier R. S., Sandler R. S., Quan H. et al., “Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial,” The New England Journal of Medicine. 2005, 352(11):1092-1102.
Alacqua M., Trifiro G., Cavagna L. et al., “Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal,” Arthritis Care and Research. 2008, 59(4):568-574.
Van Der Linden M. W., Van Der Bij S., Welsing P., Kuipers E. J., Herings R. M. C., “The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs,” Annals of the Rheumatic Diseases. 2009, 68(5):668-673.
Morrison E., Capell H. A. “Corticosteroids in the management of early and established rheumatoid disease,” Rheumatology. 2006, 45(9):1058-1061.
Makinen H., Kautiainen H., Hannonen P. et al., “Sustained remission and reduced radiographic progression with com- bination disease modifying antirheumatic drugs in early rheumatoid arthritis,” Journal of Rheumatology. 2007, 34(2):316-321.
Landewe R. B. M., Van Den Borne B. E. E. M., Breedveld F. C., Dijkmans B. A. C. “Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity,” The Lancet. 2000, 355(9215):1616-1617.
Tabit C. E., Holbrook M., Shenouda S. M. et al. “Effect of sulfasalazine on inflammation and endothelial function in patients with established coronary artery disease,” Vascular Medicine. 2012, 17(2):101-107.
Szekanecz Z., Kerekes G., Soltesz P. “Vascular effects of biologic agents in RA and spondyloarthropathies,” Nature Reviews Rheumatology, 2009, 5(12):677-684.
Da'ien C. I., Duny Y., Barnetche T., Daures J.P, Combe B., Morel J. “Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis,” Annals of the Rheumatic Diseases. 2012, 71(6):862-868.
Gonzalez M. A., Gonzalez C., Vazquez T. R., Miranda J. A., Llorca J. “Insulin resistance in rheumatoid arthritis: the impact of the anti- TNF-a therapy: annals of the New York Academy of Sciences,” Annals of the New York Academy of Sciences. 2010, 1193:153-159.
Gonzalez M. A., Garcia M. T., Gonzalez C., et al. “Anti-TNF-a therapy modulates resistin in patients with rheumatoid arthritis,” Clinical and Experimental Rheumatology. 2008, 26(2):311-316.
Hurlimann D., Forster A., Noll G., et al. “Anti-tumor necrosis factor a treatment improves endothelial function in patients with rheumatoid arthritis,” Circulation. 2002, 106(17):2184-2187.
Atzeni F., Turiel M., Caporali R. et al. “The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases,” Autoimmunity Reviews. 2010, 9(12):835-839.
Sarzi-Puttini P., Atzeni F., Shoenfeld Y., Ferraccioli G. “TNF-a, rheumatoid arthritis, and heart failure: a rheumatological dilemma,” Autoimmunity Reviews. 2005, 4(3):53-161.
Kerekes G., Soltesz P., Der H., et al. “Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis” Clinical Rheumatology. 2009, 28(6):705-710.
.
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
